The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Now, this is where there's sort of an interesting shift going on because we have these new miracle medications, right? The GLP1 inhibitors. Yeah. And one of the things they do is they actually help with insulin resistance. Right? So uh we also have the SGLT2 inhibitors and these another class of diabetic originally developed for diabetes but now indicated for treatment of heart disease, heart failure in particular. They also help with insulin resistance.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.